Baudax Bio Reports Third Quarter 2020 Financial Results
MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX) has reported financial results for the three and nine months ended September 30, 2020.
Read MoreEconomic impact of the COVID-19 pandemic
Recro Reports Second Quarter 2020 Financial Results
MALVERN, PA — Recro (Nasdaq: REPH), a leading contract development and manufacturing organization (CDMO), with integrated solutions for the development, formulation, regulatory support, manufacturing and packaging of oral solid dose …
Read More